STOCKHOLM: The Nobel medicine prize was awarded Monday (Oct 5) to American psychiatrist and neurologist Karl Deisseroth and German scientists Peter Hegemann and Georg Nagel for their pioneering work in the neuroscience field of optogenetics.
Optogenetics involves controlling nerve signals with light, and helps researchers understand how specific cell types contribute to behaviours like learning, fear, addiction and movement.
The trio were honoured “for their discovery of a molecular switch for nerve cells”, the Nobel Assembly said.
Using light, researchers are now able to switch individual neural circuits on or off in a brain.
They have been able to reveal neural circuits governing specific memories, feelings, and behaviours relevant for neurological and psychiatric disorders.
In clinical medicine, the method has been used on humans on a very limited basis, particularly to treat a specific form of blindness, and may one day lead to treatments for disorders such as Parkinson’s disease and epilepsy.
“Optogenetics provides opportunities for mapping the brain in a way that we could once only dream of,” Per Svenningsson, chair of the Nobel committee, said in a statement.
The jury said the field had “fundamentally altered our understanding of the brain”.
The secretary general of the assembly, Thomas Perlmann, told reporters he was able to reach the three laureates by phone to break the news.
“I first called Deisseroth, he was very tired when he answered. He was definitely asleep, but he woke up,” he said.
“All three said the same thing, that they thought it was absolutely wonderful to receive the prize with the other two.”
‘Seen it coming’
“This is one of those Nobel prizes that we’ve all seen coming for quite a while now,” Simon Schultz, professor of neurotechnology in the department of bioengineering at Imperial College London, said in comments sent to AFP.
“Being able to manipulate cells with a combination of light and genetics has been transformational across the biological sciences,” he said.
